Access Intelligence
Turning Payer Data Into Patient Access
Mapol helps innovative pharmaceutical manufacturers navigate Canada's private and public payer drug plans — combining payer strategy, data analytics, and stakeholder engagement from specialists who've worked both sides of the table.
Identify and remove the barriers to access
We help move your product from approval to access.
The intelligence behind smarter access decisions
Payer profiles, tools, and insights — everything essential to market access in Canada, brought together in a single subscription that shows you who the payers are, how they decide, and what's changing across private and public plans. Relied on by over 450 members across Canada's pharmaceutical companies.
An extension of your market access team
With extensive experience on both the pharmaceutical and payer sides of reimbursement, Mapol is the trusted partner manufacturers rely on for quality work and the credibility that comes from knowing how coverage decisions are actually made.
Since 2012, Mapol has supported patient access for hundreds of drugs — from submission to formulary listing.
- Deep expertise across private and public drug plans
- Daily market monitoring, translated into clear guidance
- Submission strategy grounded in how payers actually decide
- A single, focused practice — market access is our specialty
Let's talk about your payer strategy
Tell us where you are in the reimbursement journey and we'll show you where Mapol fits.
Get in touch